{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:24:44Z","timestamp":1791591884540,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Respiratory syncytial virus (RSV) infection is a major cause of morbidity in children. However, its disease burden remains poorly understood, particularly outside of the hospital setting. Our study aimed to estimate the burden of medically attended acute lower respiratory infection (ALRI) cases potentially related to RSV in Spanish children. Longitudinal data from September 2017 to June 2018 of 51,292 children aged\u2009&lt;\u20095\u2009years old from the National Healthcare System (NHS) of two Spanish regions were used. Three case definitions were considered: (a) RSV-specific; (b) RSV-specific and unspecified acute bronchiolitis (RSV-specific and Bronchiolitis), and; (c) RSV-specific and unspecified ALRI (RSV-specific and ALRI). A total of 3460 medically attended ALRI cases potentially due to RSV were identified, of which 257 (7.4%), 164 (4.7%), and 3039 (87.8%) coded with RSV-specific, unspecific bronchiolitis, and unspecific ALRI codes, respectively. Medically attended RSV-specific and ALRI cases per 1000 children was 134.4 in the first year of life, 119.4 in the second, and 35.3 between 2 and 5\u2009years old. Most cases were observed in otherwise healthy children (93.1%). Mean direct healthcare cost per medically attended RSV-specific and ALRI case was \u20ac1753 in the first year of life, \u20ac896 in the second, and \u20ac683 between 2 and 5\u2009years old. Hospitalization was the main driver of these costs, accounting for 55.6%, 38.0% and 33.4%, in each respective age group. In RSV-specific cases, mean direct healthcare cost per medically attended case was higher, mostly due to hospitalization: \u20ac3362 in the first year of life (72.9% from hospitalizations), \u20ac3252 in the second (72.1%), and \u20ac3514 between 2 and 5\u2009years old (74.2%). These findings suggest that hospitalization data alone will underestimate the RSV infections requiring medical care, as will relying only on RSV-specific codes. RSV testing and codification must be improved and preventive solutions adopted, to protect all infants, particularly during the first year of life.<\/jats:p>","DOI":"10.1186\/s12879-022-07745-0","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T06:02:45Z","timestamp":1664431365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study"],"prefix":"10.1186","volume":"22","author":[{"given":"F.","family":"Martin\u00f3n-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Platero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"L\u00f3pez-Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bangert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"D\u00edez-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garc\u00e9s-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"issue":"3","key":"7745_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40121-016-0123-0","volume":"5","author":"L Bont","year":"2016","unstructured":"Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, Sim\u00f5es EA, Carbonell-Estrany X. Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in western countries. Infect Dis therapy. 2016;5(3):271\u201398.","journal-title":"Infect Dis therapy"},{"issue":"1","key":"7745_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12916-020-01802-8","volume":"18","author":"D Hodgson","year":"2020","unstructured":"Hodgson D, Pebody R, Panovska-Griffiths J, Baguelin M, Atkins KE. Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis. BMC Med. 2020;18(1):348.","journal-title":"BMC Med"},{"issue":"10340","key":"7745_CR3","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Sim\u00f5es EAF, Campbell H, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5\u2009years in 2019: a systematic analysis. The Lancet. 2022;399(10340):2047\u201364.","journal-title":"The Lancet"},{"issue":"4","key":"7745_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ppul.23570","volume":"52","author":"RT Stein","year":"2017","unstructured":"Stein RT, Bont LJ, Zar H, Polack FP, Park C, Claxton A, Borok G, Butylkova Y, Wegzyn C. Respiratory syncytial virus hospitalization and mortality: systematic review and meta-analysis. Pediatr Pulmonol. 2017;52(4):556\u201369.","journal-title":"Pediatr Pulmonol"},{"key":"7745_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12879-014-0544-x","volume":"14","author":"J D\u00edez-Domingo","year":"2014","unstructured":"D\u00edez-Domingo J, P\u00e9rez-Yarza EG, Melero JA, S\u00e1nchez-Luna M, Aguilar MD, Blasco AJ, Alfaro N, L\u00e1zaro P. Social, economic, and health impact of the respiratory syncytial virus: a systematic search. BMC Infect Dis. 2014;14:544\u20134.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"7745_CR6","doi-asserted-by":"publisher","first-page":"e89186","DOI":"10.1371\/journal.pone.0089186","volume":"9","author":"J Murray","year":"2014","unstructured":"Murray J, Bottle A, Sharland M, Modi N, Aylin P, Majeed A, Saxena S. Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLoS ONE. 2014;9(2):e89186.","journal-title":"PLoS ONE"},{"issue":"6","key":"7745_CR7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1056\/NEJMoa0804877","volume":"360","author":"CB Hall","year":"2009","unstructured":"Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588\u201398.","journal-title":"N Engl J Med"},{"issue":"11","key":"7745_CR8","doi-asserted-by":"publisher","first-page":"e0206474","DOI":"10.1371\/journal.pone.0206474","volume":"13","author":"N Viguria","year":"2018","unstructured":"Viguria N, Mart\u00ednez-Baz I, Moreno-Galarraga L, Sierrases\u00famaga L, Salcedo B, Castilla J. Respiratory syncytial virus hospitalization in children in northern Spain. PLoS ONE. 2018;13(11):e0206474.","journal-title":"PLoS ONE"},{"issue":"2","key":"7745_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3892\/ijmm.2020.4641","volume":"46","author":"IN Mammas","year":"2020","unstructured":"Mammas IN, Drysdale SB, Rath B, Theodoridou M, Papaioannou G, Papatheodoropoulou A, Koutsounaki E, Koutsaftiki C, Kozanidou E, Achtsidis V, et al. Update on current views and advances on RSV infection (Review). Int J Mol Med. 2020;46(2):509\u201320.","journal-title":"Int J Mol Med"},{"key":"7745_CR10","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1017\/S0950268819001377","volume":"147","author":"N Prasad","year":"2019","unstructured":"Prasad N, Newbern EC, Trenholme AA, Wood T, Thompson MG, Aminisani N, Huang QS, Grant CC. Respiratory syncytial virus hospitalisations among young children: a data linkage study. Epidemiol Infect. 2019;147:e246.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"7745_CR11","doi-asserted-by":"publisher","first-page":"e0244746","DOI":"10.1371\/journal.pone.0244746","volume":"16","author":"MA Hamilton","year":"2021","unstructured":"Hamilton MA, Calzavara A, Emerson SD, Djebli M, Sundaram ME, Chan AK, Kustra R, Baral SD, Mishra S, Kwong JC. Validating International Classification of Disease 10th Revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations. PLoS ONE. 2021;16(1):e0244746.","journal-title":"PLoS ONE"},{"issue":"6","key":"7745_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/irv.12665","volume":"14","author":"W Cai","year":"2020","unstructured":"Cai W, Tolksdorf K, Hirve S, Schuler E, Zhang W, Haas W, Buda S. Evaluation of using ICD-10 code data for respiratory syncytial virus surveillance. Influenza Other Respir Viruses. 2020;14(6):630\u20137.","journal-title":"Influenza Other Respir Viruses"},{"issue":"3","key":"7745_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/INF.0000000000000993","volume":"35","author":"C Mu\u00f1oz-Quiles","year":"2016","unstructured":"Mu\u00f1oz-Quiles C, L\u00f3pez-Lacort M, \u00dabeda-Sansano I, Alem\u00e1n-S\u00e1nchez S, P\u00e9rez-Vilar S, Puig-Barber\u00e0 J, D\u00edez-Domingo J. Population-based Analysis of Bronchiolitis Epidemiology in Valencia, Spain. Pediatr Infect Dis J. 2016;35(3):275\u201380.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"7745_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12879-022-07261-1","volume":"22","author":"M Heppe-Montero","year":"2022","unstructured":"Heppe-Montero M, Walter S, Hern\u00e1ndez-Barrera V, Gil-Prieto R, Gil-de-Miguel \u00c1. Burden of respiratory syncytial virus-associated lower respiratory infections in children in Spain from 2012 to 2018. BMC Infect Dis. 2022;22(1):315.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"7745_CR15","doi-asserted-by":"publisher","first-page":"1883379","DOI":"10.1080\/21645515.2021.1883379","volume":"18","author":"M Heppe Montero","year":"2022","unstructured":"Heppe Montero M, Gil-Prieto R, Walter S, Aleixandre Blanquer F, Gil De Miguel \u00c1. Burden of severe bronchiolitis in children up to 2\u2009years of age in Spain from 2012 to 2017. Hum vaccines immunotherapeutics. 2022;18(1):1883379.","journal-title":"Hum vaccines immunotherapeutics"},{"issue":"9","key":"7745_CR16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/infdis\/jiy056","volume":"217","author":"P Obando-Pacheco","year":"2018","unstructured":"Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodr\u00edguez-Tenreiro C, Sly P, Ramilo O, Mej\u00edas A, Baraldi E, Papadopoulos NG, Nair H, et al. Respiratory syncytial virus seasonality: a global overview. J Infect Dis. 2018;217(9):1356\u201364.","journal-title":"J Infect Dis"},{"issue":"2","key":"7745_CR17","doi-asserted-by":"publisher","first-page":"e54445","DOI":"10.1371\/journal.pone.0054445","volume":"8","author":"K Bloom-Feshbach","year":"2013","unstructured":"Bloom-Feshbach K, Alonso WJ, Charu V, Tamerius J, Simonsen L, Miller MA, Viboud C. Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS ONE. 2013;8(2):e54445.","journal-title":"PLoS ONE"},{"issue":"1","key":"7745_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/21645515.2017.1403707","volume":"14","author":"S Janet","year":"2018","unstructured":"Janet S, Broad J, Snape MD. Respiratory syncytial virus seasonality and its implications on prevention strategies. Hum Vacc Immunothera. 2018;14(1):234\u201344.","journal-title":"Hum Vacc Immunothera"},{"key":"7745_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.gaceta.2018.11.009","volume":"34","author":"M Servia-Dopazo","year":"2020","unstructured":"Servia-Dopazo M, Purri\u00f1os-Hermida MJ, P\u00e9rez S, Garc\u00eda J, Malvar-Pintos A. Utilidad de la vigilancia microbiol\u00f3gica del virus respiratorio sincitial en Galicia (Espa\u00f1a): 2008\u20132017. Gac Sanit. 2020;34:474\u20139.","journal-title":"Gac Sanit"},{"issue":"1","key":"7745_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12889-015-1885-0","volume":"15","author":"B Ehlken","year":"2015","unstructured":"Ehlken B, Anastassopoulou A, Hain J, Schr\u00f6der C, Wahle K. Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany\u2014results of a database analysis from May 2010 to April 2012. BMC Public Health. 2015;15(1):578.","journal-title":"BMC Public Health"},{"key":"7745_CR21","unstructured":"eSalud-Informaci\u00f3n econ\u00f3mica del sector sanitario http:\/\/oblikue.com\/bddcostes\/."},{"issue":"2","key":"7745_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1134-282X(01)77392-7","volume":"16","author":"L Garc\u00eda-Eroles","year":"2001","unstructured":"Garc\u00eda-Eroles L, Illa C, Arias A, Casas M. Los Top 20 2000: objetivos, ventajas y limitaciones del m\u00e9todo. Rev Calidad Asistencial. 2001;16(2):107\u201316.","journal-title":"Rev Calidad Asistencial."},{"issue":"3","key":"7745_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10729-006-9089-x","volume":"9","author":"F S\u00e1nchez-Mart\u00ednez","year":"2006","unstructured":"S\u00e1nchez-Mart\u00ednez F, Abell\u00e1n-Perpi\u00f1\u00e1n JM, Mart\u00ednez-P\u00e9rez JE, Puig-Junoy J. Cost accounting and public reimbursement schemes in Spanish hospitals. Health Care Manag Sci. 2006;9(3):225\u201332.","journal-title":"Health Care Manag Sci"},{"issue":"6","key":"7745_CR24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1067\/mpd.2000.110531","volume":"137","author":"TG Boyce","year":"2000","unstructured":"Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr. 2000;137(6):865\u201370.","journal-title":"J Pediatr"},{"issue":"6","key":"7745_CR25","doi-asserted-by":"publisher","first-page":"e1453","DOI":"10.1542\/peds.2010-0507","volume":"126","author":"CG Garc\u00eda","year":"2010","unstructured":"Garc\u00eda CG, Bhore R, Soriano-Fallas A, Trost M, Chason R, Ramilo O, Mejias A. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics. 2010;126(6):e1453\u201360.","journal-title":"Pediatrics"},{"issue":"2","key":"7745_CR26","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1542\/peds.2013-0303","volume":"132","author":"CB Hall","year":"2013","unstructured":"Hall CB, Weinberg GA, Blumkin AK, Edwards KM, Staat MA, Schultz AF, Poehling KA, Szilagyi PG, Griffin MR, Williams JV, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24\u2009months of age. Pediatrics. 2013;132(2):e341\u20138.","journal-title":"Pediatrics"},{"issue":"5","key":"7745_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/jpids\/piz087","volume":"9","author":"CS Arriola","year":"2020","unstructured":"Arriola CS, Kim L, Langley G, Anderson EJ, Openo K, Martin AM, Lynfield R, Bye E, Como-Sabetti K, Reingold A, et al. Estimated burden of community-onset respiratory syncytial virus-associated hospitalizations among children aged < 2 years in the United States, 2014\u201315. J Pediatr Infect Dis Soc. 2020;9(5):587\u201395.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"Suppl B","key":"7745_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/rmed.2002.1295","volume":"96","author":"Y Aujard","year":"2002","unstructured":"Aujard Y, Fauroux B. Risk factors for severe respiratory syncytial virus infection in infants. Respir Med. 2002;96(Suppl B):9\u201314.","journal-title":"Respir Med"},{"issue":"21","key":"7745_CR29","doi-asserted-by":"publisher","first-page":"e831","DOI":"10.1097\/MD.0000000000000831","volume":"94","author":"R Gil-Prieto","year":"2015","unstructured":"Gil-Prieto R, Gonzalez-Escalada A, Mar\u00edn-Garc\u00eda P, Gallardo-Pino C, Gil-de-Miguel A. Respiratory syncytial virus bronchiolitis in children up to 5 years of age in Spain: epidemiology and comorbidities: an observational study. Medicine. 2015;94(21):e831.","journal-title":"Medicine"},{"issue":"10098","key":"7745_CR30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","volume":"390","author":"T Shi","year":"2017","unstructured":"Shi T, McAllister DA, O\u2019Brien KL, Simoes EAF, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo C, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet (London England). 2017;390(10098):946\u201358.","journal-title":"Lancet (London England)"},{"key":"7745_CR31","doi-asserted-by":"crossref","unstructured":"Mendes-da-Silva A, Gon\u00e7alves Pinho M, Freitas A, Azevedo I. Trends in hospitalization for acute bronchiolitis in Portugal: 2000\u20132015. Pulmonology. 2018; 25.","DOI":"10.1183\/13993003.congress-2018.PA1347"},{"key":"7745_CR32","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez de Dios J, Ochoa Sangrador C. Estudio de variabilidad en el abordaje de la bronquiolitis aguda en Espa\u00f1a en relaci\u00f3n con la edad de los pacientes. Anal Pediatr. 2010; 72(1):4\u201318.","DOI":"10.1016\/j.anpedi.2009.10.006"},{"issue":"4","key":"7745_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00006454-200004000-00006","volume":"19","author":"T JUV\u00e9N","year":"2000","unstructured":"JUV\u00e9N T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, Eskola J, Saikku P, Ruuskanen O. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19(4):293\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"9773","key":"7745_CR34","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","volume":"377","author":"O Ruuskanen","year":"2011","unstructured":"Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. The Lancet. 2011;377(9773):1264\u201375.","journal-title":"The Lancet"},{"key":"7745_CR35","unstructured":"Simoes EA, Cherian T, Chow J, Shahid-Salles SA, Laxminarayan R, John TJ.\u00a0Acute respiratory infections in children. Disease Control Priorities in Developing Countries 2nd edition 2006."},{"issue":"9181","key":"7745_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(99)80040-3","volume":"354","author":"EA Simoes","year":"1999","unstructured":"Simoes EA. Respiratory syncytial virus infection. The Lancet. 1999;354(9181):847\u201352.","journal-title":"The Lancet"},{"key":"7745_CR37","unstructured":"Pneumonia. Key facts. http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/pneumonia."},{"issue":"7","key":"7745_CR38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/cid\/cix923","volume":"66","author":"P Fathima","year":"2018","unstructured":"Fathima P, Blyth CC, Lehmann D, Lim FJ, Abdalla T, De Klerk N, Moore HC. The impact of pneumococcal vaccination on bacterial and viral pneumonia in Western Australian children: record linkage cohort study of 469589 births, 1996\u20132012. Clin Infect Dis. 2018;66(7):1075\u201385.","journal-title":"Clin Infect Dis"},{"key":"7745_CR39","unstructured":"Griffin MR, Mitchel E, Moore MR, Whitney CG, Grijalva CG. Declines in pneumonia hospitalizations of children aged < 2\u2009years associated with the use of pneumococcal conjugate vaccines\u2014Tennessee, 1998\u20132012. Morbid Mortal Wkly Rep.\u00a02014; 63(44):995."},{"issue":"3","key":"7745_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/thoraxjnl-2018-212096","volume":"74","author":"MU Bhuiyan","year":"2019","unstructured":"Bhuiyan MU, Snelling TL, West R, Lang J, Rahman T, Granland C, de Gier C, Borland ML, Thornton RB, Kirkham L-AS, et al. The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case\u2013 control study. Thorax. 2019;74(3):261\u20139.","journal-title":"Thorax"},{"issue":"1","key":"7745_CR41","doi-asserted-by":"publisher","first-page":"010408","DOI":"10.7189\/jogh.05.010408","volume":"5","author":"T Shi","year":"2015","unstructured":"Shi T, McLean K, Campbell H, Nair H. Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: a systematic review and meta-analysis. J Global Health. 2015;5(1):010408.","journal-title":"J Global Health"},{"issue":"7","key":"7745_CR42","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00431-012-1673-0","volume":"171","author":"D Shefali-Patel","year":"2012","unstructured":"Shefali-Patel D, Paris MA, Watson F, Peacock JL, Campbell M, Greenough A. RSV hospitalisation and healthcare utilisation in moderately prematurely born infants. Eur J Pediatr. 2012;171(7):1055\u201361.","journal-title":"Eur J Pediatr"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07745-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07745-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07745-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T06:04:27Z","timestamp":1664431467000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07745-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7745"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07745-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"3 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the ethical principles of the Declaration of Helsinki and the local regulation, including privacy laws. The protocol of the BARI study was validated by a panel of clinical experts, classified by the Agency of Medicines and Medical Devices (AEMPS) as an observational study and approved by the Ethics Committee of Hospital Clinic de Barcelona (HCB\/2020\/1132). Informed consent to participate was waived by the same ethics committee that approved the study (Ethics Committee of Hospital Clinic de Barcelona).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Platero L, Drago G, L\u00f3pez-Belmonte JL and Bangert M are Sanofi employees and may hold shares and\/or stock options in the company. Carmo M is an IQVIA employee. Martin\u00f3n Torres F and D\u00edez-Domingo J have received fees from Sanofi. F.M-T. received honoraria from GSK group of companies, Pfizer Inc, Sanofi Pasteur, MSD, Seqirus, and Janssen for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work. FM-T has also acted as principal investigator in randomized controlled trials of the above-mentioned companies as well as Ablynx, Gilead, Regeneron, Roche, Abbott, Novavax, and MedImmune, with honoraria paid to his institution. F.M-T has received support for the present work from the Instituto de Salud Carlos III (Proyecto de Investigaci\u00f3n en Salud, Acci\u00f3n Estrat\u00e9gica en Salud): Fondo de Investigaci\u00f3n Sanitaria (FIS; PI070069\/PI1000540\/PI1601569\/PI1901090) del plan nacional de I\u2009+\u2009D\u2009+\u2009I and \u2018fondos FEDER\u2019 and Proyectos GaIN Rescata-Covid_IN845D 2020\/23 (GAIN, Xunta de Galicia). Garc\u00e9s-S\u00e1nchez M received honoraria from GSK, Pfizer Inc, Sanofi and MSD for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"759"}}